Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.

Poolman M, Wright S, Hendry A, Goulden N, Holmes E, Byrne A, Perkins P, Hoare Z, Nelson A, Hiscock J, Hughes DA, O'Connor J, Foster B, Reymond L, Lewis P, Wee B, Roberts R, Parkinson A, Roberts S, Wilkinson C

Open source

DOI
10.1136/bmjopen-2024-084476
Published
2025 Jun 12
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2024-084476,
  title = {Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.},
  author = {Poolman M and Wright S and Hendry A and Goulden N and Holmes E and Byrne A and Perkins P and Hoare Z and Nelson A and Hiscock J and Hughes DA and O'Connor J and Foster B and Reymond L and Lewis P and Wee B and Roberts R and Parkinson A and Roberts S and Wilkinson C},
  year = {2025},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2024-084476},
  url = {https://doi.org/10.1136/bmjopen-2024-084476}
}

RIS

TY  - JOUR
TI  - Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
AU  - Poolman M
AU  - Wright S
AU  - Hendry A
AU  - Goulden N
AU  - Holmes E
AU  - Byrne A
AU  - Perkins P
AU  - Hoare Z
AU  - Nelson A
AU  - Hiscock J
AU  - Hughes DA
AU  - O'Connor J
AU  - Foster B
AU  - Reymond L
AU  - Lewis P
AU  - Wee B
AU  - Roberts R
AU  - Parkinson A
AU  - Roberts S
AU  - Wilkinson C
PY  - 2025
JO  - BMJ open
DO  - 10.1136/bmjopen-2024-084476
UR  - https://doi.org/10.1136/bmjopen-2024-084476
ER  - 

APA

M, P., S, W., A, H., N, G., E, H., A, B., P, P., Z, H., A, N., J, H., DA, H., J, O., B, F., L, R., P, L., B, W., R, R., A, P., S, R., & C, W. (2025). Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.. BMJ open. https://doi.org/10.1136/bmjopen-2024-084476

Source records